Trends in aggregate use and associated expenditures of antihyperglycemic therapies among US Medicare beneficiaries between 2012 and 2017.
Open accessAbstract
A survey of internal medicine residents about their professional preferences, their perceptions of cardiology, and how these attitudes combine to inform career choices showed substantial sex differences.5 More women than men reported never considering cardiology, and women had different perceptions of cardiology than men.Women cardiologists are more likely than men to experience sex and parenting discrimination, be single, not have children, and report less satisfaction in family life, though overall career satisfaction remains high for both men and women.6 A limitation of our study is the use of publicly available data that were aggregated with no individual identifiers.From 1991 to 2016, there have been increases in the percentage of women in 9 medical subspecialties but substantial differences between specialties remain.As compared with the other 8 subspecialties, cardiology had the lowest percentage of women, which is an important issue that the cardiology profession should continue to address.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the US, the 2020 national median drug acquisition cost of GLP-1RAs ranges from $634 per month to $835 per month.
“In the US, the 2020 national median drug acquisition cost of GLP-1RAs ranges from $634 per month to $835 per month,27·41 although the out-of-pocket cost borne by patients varies considerably by insurance formulary and coverage.”
From Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review (2020) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
9. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2019</i>
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s009 · Cited by 739 · see citing works
Dennis, J., Henley, W., McGovern, A. P., Farmer, A. A., Sattar, N. A., Holman, R. R., Pearson, E. R., Hattersley, A. T., Shields, B. M., & Jones, A. G. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13687 · Cited by 80 · see citing works
Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018
Hernandez, I., Good, C. B., Shrank, W. H., & Gellad, W. F. (2019) · JAMA · doi:10.1001/jama.2019.2990 · Cited by 26 · see citing works
Flagged first, then by citations
1 of the 4 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Khan, M. S., Fonarow, G. C., McGuire, D. K., Hernandez, A. F., Vaduganathan, M., Rosenstock, J., Handelsman, Y., Verma, S., Anker, S. D., McMurray, J. J. V., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.045888 · Cited by 139 · see citing works
Self-citationHonigberg, M. C., Chang, L.-S., McGuire, D. K., Plutzky, J., Aroda, V. R., & Vaduganathan, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1966 · Cited by 127 · see citing works
Self-citationSodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction
Udell, J. A., Jones, W. S., Petrie, M. C., Harrington, J., Anker, S. D., Bhatt, D. L., Hernandez, A. F., & Butler, J. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.03.353 · Cited by 108 · see citing works
Self-citationKhera, R., Kondamudi, N., Zhong, L., Vaduganathan, M., Parker, J., Das, S. R., Grodin, J. L., Halm, E. A., Berry, J. D., & Pandey, A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.22190 · Cited by 87 · see citing works
Self-citationContemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF
Vaduganathan, M., Fonarow, G. C., Greene, S. J., DeVore, A. D., Kavati, A., Sikirica, S., Albert, N. M., Duffy, C. I., Hill, C. L., Patterson, J. H., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.12.015 · Cited by 86 · see citing works
Self-citationGreiver, M., Havard, A., Bowles, J., Kalia, S., Chen, T., Aliarzadeh, B., Moineddin, R., Sherlock, J., Hinton, W., Sullivan, F., et al. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x714089 · Cited by 45 · see citing works
Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D
DeJong, C., Masuda, C., Chen, R., Kazi, D. S., Dudley, R. A., & Tseng, C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.2922 · Cited by 42 · see citing works
Inoue, K., Tsugawa, Y., Mangione, C. M., & Duru, O. K. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003645 · Cited by 28 · see citing works
Medicaid Expansion and Utilization of Antihyperglycemic Therapies
Sumarsono, A., Buckley, L. F., Machado, S., Wadhera, R. K., Warraich, H. J., Desai, R. J., Everett, B. M., McGuire, D. K., Fonarow, G. C., Butler, J., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0735 · Cited by 22 · see citing works
Self-citationVaduganathan, M., Inzucchi, S. E., Sattar, N. A., FITCHETT, D. H., Ofstad, A. P., Brueckmann, M., George, J. T., Verma, S., Mattheus, M., Wanner, C., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14535 · Cited by 21 · see citing works
Self-citationRashid, Z., Woldesenbet, S., Khalil, M., Iyer, S., Khan, M. M. M., Altaf, A., Munir, M. M., Catalano, G., Mumtaz, K., & Pawlik, T. M. (2024) · Liver International · doi:10.1111/liv.16132 · Cited by 20 · see citing works
Changes in Type 2 Diabetes Medication Utilization and Costs in the United States, 2014–2019
Neilson, L. M., Munshi, K. D., Peasah, S. K., Huang, Y., Swart, E. C. S., Henderson, R. R., Manolis, C. H., & Good, C. B. (2021) · Medical Care · doi:10.1097/mlr.0000000000001597 · Cited by 16 · see citing works
Inoue, K., Saliba, D., Gotanda, H., Moin, T., Mangione, C. M., Klomhaus, A. M., & Tsugawa, Y. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-02648 · Cited by 17 · see citing works
Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016
Zhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2021) · Kidney Medicine · doi:10.1016/j.xkme.2020.09.016 · Cited by 9 · see citing works
Temporal trends in cardiovascular outcomes and costs among patients with type 2 diabetes
Williams, B. A., RAJPURA, J. R., Paprocki, Y., Kumar, N., Voyce, S. J., Brady, J. P., & Chang, A. R. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.07.012 · Cited by 6 · see citing works
Williams, B. A., Brady, J. P., Voyce, S. J., Kumar, N., Paprocki, Y., & RAJPURA, J. R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14686 · Cited by 5 · see citing works
Trends in Industry Payments to Physicians for Antihyperglycemic Therapies Between 2014 and 2018
Inoue, K., Duru, O. K., Mangione, C. M., & Tsugawa, Y. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06215-0 · Cited by 4 · see citing works
Suzuki, R., Shoji, S., Yoshinaga, Y., Kosakai, Y., & Shintani‐Tachi, M. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16188 · Cited by 3 · see citing works
Implications of the recent CVOTs in type 2 diabetes: The right place for DPP-IV inhibitors today
Bloomgarden, Z. T. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107906 · Cited by 2 · see citing works
Hubungan Motivasi Dengan Keaktifan Kader Posyandu Wilayah Kerja Puskesmas Gunung Tabur Tahun 2020
Kamba, I., Ratno, R., Ningsih, S., & Arwan, A. (2021) · Preventif Jurnal Kesehatan Masyarakat · doi:10.22487/preventif.v12i2.440
Pandey, A., Patel, K. V., & Verma, S. (2024) · doi:10.1002/9781119697473.ch50
Self-citation
- Authors
- Sumarsono, A., Everett, B. M., McGuire, D. K., Fonarow, G. C., Butler, J., Pandey, A., & Vaduganathan, M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Brigham and Women's Hospital (US)
- University of California, Los Angeles (US)
- University of Mississippi Medical Center (US)
- Corresponding author
- Vaduganathan, Muthiah
- ORCID
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2020-01-01
- Volume
- 180
- Issue
- 1
- Pages
- 141
- ISSN
- 2168-6106 (ISSN-L)
- PMC
- PMC6777260
- OpenAlex
- W2976104247
- Cited by
- 21
- References
- 4
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 9 · 2019: 1
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Internal Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Sanofi
- Patient-Centered Outcomes Research Institute
- Harvard Catalyst (UL1TR002541, 1TR002541)
- Amarin Corporation
- European Commission
- Eisai
- Novo Nordisk
- Esperion Therapeutics
- National Institutes of Health (UL1TR002541)
- Centers for Disease Control and Prevention
- Relypsa
- National Heart, Lung, and Blood Institute
- National Institute of General Medical Sciences (U54GM115428)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences (1TR002541)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Social Sciences › Gender Studies › Diversity and Career in Medicine
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Keywords
- antihyperglycemic therapy, Medicare beneficiaries, health care expenditure, prescription drug use, women in cardiology, internal medicine residents, gender discrimination in medicine
- MeSH terms
- Health Expenditures, Medicare, Humans, Hypoglycemic Agents, Retrospective Studies, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
